Despite the availability of appropriate prophylaxis,
thromboprophylaxis is prescribed for only approximately
50%
of
all
eligible
patients
with
AF.
There is a
clear need to improve the quality of care for these
patients. Current quality measures for providers of
treatment for AF broadly assess adherence to 3 primary
areas of stroke prevention